Асосий контентга ўтиш
AkademIndex

Маҳсулотлар

Ишлаб чиқувчилар учун

AkademBaseЭкотизим учун очиқ API

Nargiza Parpieva

49 та иш

University College London

  1. A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis

    Bern-Thomas Nyang’wa, Catherine Berry, Emil Kazounis +15

    МақолаTuberculosis Research and EpidemiologyNew England Journal of Medicine20225 иқтибос
    ABI

  2. Factors Associated with Unfavorable Treatment Outcomes in New and Previously Treated TB Patients in Uzbekistan: A Five Year Countrywide Study

    Jamshid Gadoev, Damin Asadov, Mirzagolib Tillashaykhov +14

    МақолаTuberculosis Research and EpidemiologyPLoS ONE20154 иқтибос
    ABI

  3. Where there is hope: a qualitative study examining patients’ adherence to multi-drug resistant tuberculosis treatment in Karakalpakstan, Uzbekistan

    Shona Horter, Beverley Stringer, Jane Greig +5

    МақолаTuberculosis Research and EpidemiologyBMC Infectious Diseases20164 иқтибос
    ABI

  4. Modelling the effect of short-course multidrug-resistant tuberculosis treatment in Karakalpakstan, Uzbekistan

    James M. Trauer, Jay Achar, Nargiza Parpieva +7

    МақолаTuberculosis Research and EpidemiologyBMC Medicine20163 иқтибос
    ABI

  5. Person-centred care in practice: perspectives from a short course regimen for multi-drug resistant tuberculosis in Karakalpakstan, Uzbekistan

    Shona Horter, Beverley Stringer, Nell Gray +5

    МақолаTuberculosis Research and EpidemiologyBMC Infectious Diseases20203 иқтибос
    ABI

  6. Acquired bedaquiline resistance in Karakalpakstan, Uzbekistan

    Parvati Nair, T. Hasan, K. K. Zaw +9

    МақолаTuberculosis Research and EpidemiologyThe International Journal of Tuberculosis and Lung Disease20223 иқтибос
    ABI

  7. ‘They prefer hidden treatment': anti-tuberculosis drug-taking practices and drug regulation in Karakalpakstan

    Beverley Stringer, Karen Lowton, Mirzagaleb N. Tillashaikhov +5

    МақолаTuberculosis Research and EpidemiologyThe International Journal of Tuberculosis and Lung Disease20162 иқтибос
    ABI

  8. Trends, Characteristics and Treatment Outcomes of Patients with Drug-Resistant Tuberculosis in Uzbekistan: 2013–2018

    Khasan Safaev, Nargiza Parpieva, Irina Liverko +5

    МақолаTuberculosis Research and EpidemiologyInternational Journal of Environmental Research and Public Health20212 иқтибос
    ABI

  9. Scaling Up Molecular Diagnostic Tests for Drug-Resistant Tuberculosis in Uzbekistan from 2012–2019: Are We on the Right Track?

    Sharofiddin Yuldashev, Nargiza Parpieva, Salikhdjan Alimov +6

    МақолаTuberculosis Research and EpidemiologyInternational Journal of Environmental Research and Public Health20212 иқтибос
    ABI

  10. Impact of pyrazinamide resistance on multidrug-resistant tuberculosis in Karakalpakstan, Uzbekistan

    Johanna Kuhlin, Chris Smith, Atadjan Khaemraev +8

    МақолаTuberculosis Research and EpidemiologyThe International Journal of Tuberculosis and Lung Disease20181 иқтибос
    ABI

  11. Standardised shorter regimens <i>versus</i> individualised longer regimens for rifampin- or multidrug-resistant tuberculosis

    S.K. Abidi, Jay Achar, M.M. Assao Neino +34

    МақолаTuberculosis Research and EpidemiologyEuropean Respiratory Journal20191 иқтибос
    ABI

  12. Population structure of drug-resistant Mycobacterium tuberculosis in Central Asia

    A. Engström, Uladzimir Antonenka, Abdylat Kadyrov +10

    МақолаTuberculosis Research and EpidemiologyBMC Infectious Diseases20191 иқтибос
    ABI

  13. Treatment Compliance of Multidrug Resistant Tuberculosis in Uzbekistan: Does Practice Follow Policy?

    Ruzilya Usmanova, Nargiza Parpieva, Hayk Davtyan +6

    МақолаTuberculosis Research and EpidemiologyInternational Journal of Environmental Research and Public Health20211 иқтибос
    ABI

  14. Effectiveness and Safety of a Shorter Treatment Regimen in a Setting with a High Burden of Multidrug-Resistant Tuberculosis

    Aleksandr Trubnikov, Arax Hovhannesyan, Kristina Akopyan +5

    МақолаTuberculosis Research and EpidemiologyInternational Journal of Environmental Research and Public Health20211 иқтибос
    ABI

  15. Risk Factors for Unfavorable Treatment Outcomes among the Human Immunodeficiency Virus-Associated Tuberculosis Population in Tashkent City, Uzbekistan: 2013–2017

    Sherali Massavirov, Kristina Akopyan, Fazlkhan Abdugapparov +5

    МақолаTuberculosis Research and EpidemiologyInternational Journal of Environmental Research and Public Health20211 иқтибос
    ABI

  16. Outcomes with a shorter multidrug-resistant tuberculosis regimen from Karakalpakstan, Uzbekistan

    Philipp du Cros, Atadjan Khamraev, Zinaida Tigay +15

    МақолаTuberculosis Research and EpidemiologyERJ Open Research20201 иқтибос
    ABI

  17. Patient and health-care worker perspectives on the short-course regimen for treatment of drug-resistant tuberculosis in Karakalpakstan, Uzbekistan

    Shona Horter, Jay Achar, Nell Gray +4

    МақолаTuberculosis Research and EpidemiologyPLoS ONE20201 иқтибос
    ABI

  18. Diagnostic Procedures, Diagnoses, and Treatment Outcomes of Patients with Presumptive Tuberculosis Pleural Effusion in Uzbekistan

    Fazlkhan Abdugapparov, Ruzanna Grigoryan, Nargiza Parpieva +7

    МақолаPleural and Pulmonary DiseasesInternational Journal of Environmental Research and Public Health20211 иқтибос
    ABI

  19. [Features of disruption of certain components of carbohydrate metabolism in a combination of pulmonary tuberculosis and diabetes mellitus in people with haptoglobin phenotypes].

    Nargiza Parpieva, K S Kazakov

    МақолаErythrocyte Function and PathophysiologyPubMed20010 иқтибос
    ABI

  20. Mutations in the genes of drug-resistant mycobacterium tuberculosis in Uzbekistan

    Nargiza Parpieva, Vera Beloserkoves, Khasan Safaev +1

    МақолаTuberculosis Research and EpidemiologyEuropean Respiratory Journal20140 иқтибос
    ABI

  21. Multidrug-Resistant Tuberculosis in Child Successfully Treated with 9-Month Drug Regimen

    Jay Achar, Catherine Berry, Krzysztof Herboczek +7

    БошқаTuberculosis Research and EpidemiologyEmerging infectious diseases20150 иқтибос
    ABI

  22. Recurrent tuberculosis and associated factors: A five - year countrywide study in Uzbekistan

    Jamshid Gadoev, Damin Asadov, Anthony Harries +9

    МақолаTuberculosis Research and EpidemiologyPLoS ONE20170 иқтибос
    ABI

  23. Outcomes of HIV-infected versus HIV-non-infected patients treated for drug-resistance tuberculosis: Multicenter cohort study

    Mathieu Bastard, Elisabeth Sánchez-Padilla, Philipp du Cros +12

    МақолаTuberculosis Research and EpidemiologyPLoS ONE20180 иқтибос
    ABI

  24. Surgical approach in multi- and extensively drug-resistant tuberculosis: resection and thoracomioplasty

    Askar Zetov, Kulakhmed Erimbetov, Nargiza Parpieva +2

    МақолаTuberculosis Research and EpidemiologyElectronic Journal of General Medicine20190 иқтибос
    ABI

  25. The center for distance learning and monitoring in education of tb specialists and medical students

    Sanajr Sultanov, Nargiza Parpieva, Kozim Mukhamedov

    МақолаEconomic and Industrial Development20190 иқтибос
    ABI